About Endosome-associated-trafficking regulator 1
Endosome-associated-trafficking regulator 1 (ENTR1) is a protein
from Homo sapiens identified by UniProt accession
Q96C92, 435 residues long.
MolForge cross-references it against 0 known binders and
78 disease associations.
Target properties
| Protein name | Endosome-associated-trafficking regulator 1 |
| UniProt accession | Q96C92 |
| Gene | ENTR1 |
| Organism | Homo sapiens |
| Length | 435 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (78)
Diseases linked to this target (Open Targets).
- glucose measurement · score 0.15
- Red cell distribution width · score 0.12
- leukocyte count · score 0.10
- Crohn's disease · score 0.08
- low density lipoprotein cholesterol measurement · score 0.07
- apolipoprotein B measurement · score 0.06
- chronotype measurement · score 0.06
- total cholesterol measurement · score 0.05
- blood protein measurement · score 0.05
- neutrophil percentage of leukocytes · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96C92-F1 | alphafold | PREDICTED | 64.61 | — |
Amino-acid sequence (435 residues)
MSGYQRRPGA TPLSRARSLA IPDAPAFYER RSCLPQLNCE RPHGRDLDSP FFGIRPAFMC YVPSPVLASV GDTDFGYGKG KCSKQSPSGA HGTHFGDDRF EDLEEANPFS FREFLKTKNL GLSKEDPASR IYAKEASRHS LGLDHNSPPS QTGGYGLEYQ QPFFEDPTGA GDLLDEEEDE DTGWSGAYLP SAIEQTHPER VPAGTSPCST YLSFFSTPSE LAGPESLPSW ALSDTDSRVS PASPAGSPSA DFAVHGESLG DRHLRTLQIS YDALKDENSK LRRKLNEVQS FSEAQTEMVR TLERKLEAKM IKEESDYHDL ESVVQQVEQN LELMTKRAVK AENHVVKLKQ EISLLQAQVS NFQRENEALR CGQGASLTVV KQNADVALQN LRVVMNSAQA SIKQLVSGAE TLNLVAEILK SIDRISEVKD EEEDS
Explore Endosome-associated-trafficking regulator 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets